awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35696743-2660086F-59D1-4982-81F9-3A7AF9276A32
Q35696743-2660086F-59D1-4982-81F9-3A7AF9276A32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35696743-2660086F-59D1-4982-81F9-3A7AF9276A32
Bevacizumab in the treatment of metastatic breast cancer: friend or foe?
P2860
Q35696743-2660086F-59D1-4982-81F9-3A7AF9276A32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35696743-2660086F-59D1-4982-81F9-3A7AF9276A32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a42045cb494ab759389ef80d9a6dba8e886dab5
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.